Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf Berger

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Expert Opinion on Investigational Drugs|February 28, 2002
Endothelin receptor antagonists in cardiology clinical trialsThomas Neunteufl, Rudolf Berger, Richard Pacher
BMC Public Health|May 25, 2019
The role of the socio-economic environment on medical outcomes after ST-segment elevation myocardial infarctionChristian Roth, Rudolf Berger, Michael Kuhn
European Journal of Heart Failure|June 1, 2005
Influence of age and in-patient care on prescription rate and long-term outcome in chronic heart failure: a data-based substudy of the EuroHeart Failure SurveyMartin Hülsmann, Rudolf Berger, Deddo Mörtl, et al.
Wiener Klinische Wochenschrift|May 31, 2019
Curriculum heart failure : Task force curriculum heart failure of the working group on heart failure of the Austrian Cardiological SocietyRudolf Berger, Martin Hülsmann, Deddo Mörtl, et al.
International Journal of Technology Assessment in Health Care|December 22, 2012
Cost-utility analysis of nt-probnp-guided multidisciplinary care in chronic heart failureDeddo Moertl, Sabine Steiner, Doug Coyle, et al.
American Heart Journal|February 9, 2002
Prognostic impact of workload in patients with congestive heart failureMartin Huelsmann, Thomas Stefenelli, Rudolf Berger, et al.
European Journal of Heart Failure|August 9, 2005
Short-term effects of levosimendan and prostaglandin E1 on hemodynamic parameters and B-type natriuretic peptide levels in patients with decompensated chronic heart failureDeddo Moertl, Rudolf Berger, Martin Huelsmann, et al.
European Journal of Heart Failure|March 25, 2008
Prognostic value of sequential measurements of amino-terminal prohormone of B-type natriuretic peptide in ambulatory heart failure patientsDeddo Moertl, Alexandra Hammer, Martin Huelsmann, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 22, 2004
Neurohumoral and hemodynamic effects of the selective endothelin antagonist darusentan in advanced chronic heart failureJutta Bergler-Klein, Richard Pacher, Rudolf Berger, et al.
BMJ Open|July 12, 2022
Socioeconomic environment and survival in patients after ST-segment elevation myocardial infarction (STEMI): a longitudinal study for the City of ViennaSonja Spitzer, Vanessa di Lego, Michael Kuhn, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Expert Opinion on Investigational Drugs|February 28, 2002
Endothelin receptor antagonists in cardiology clinical trialsThomas Neunteufl, Rudolf Berger, Richard Pacher
BMC Public Health|May 25, 2019
The role of the socio-economic environment on medical outcomes after ST-segment elevation myocardial infarctionChristian Roth, Rudolf Berger, Michael Kuhn
European Journal of Heart Failure|June 1, 2005
Influence of age and in-patient care on prescription rate and long-term outcome in chronic heart failure: a data-based substudy of the EuroHeart Failure SurveyMartin Hülsmann, Rudolf Berger, Deddo Mörtl, et al.
Wiener Klinische Wochenschrift|May 31, 2019
Curriculum heart failure : Task force curriculum heart failure of the working group on heart failure of the Austrian Cardiological SocietyRudolf Berger, Martin Hülsmann, Deddo Mörtl, et al.
International Journal of Technology Assessment in Health Care|December 22, 2012
Cost-utility analysis of nt-probnp-guided multidisciplinary care in chronic heart failureDeddo Moertl, Sabine Steiner, Doug Coyle, et al.
American Heart Journal|February 9, 2002
Prognostic impact of workload in patients with congestive heart failureMartin Huelsmann, Thomas Stefenelli, Rudolf Berger, et al.
European Journal of Heart Failure|August 9, 2005
Short-term effects of levosimendan and prostaglandin E1 on hemodynamic parameters and B-type natriuretic peptide levels in patients with decompensated chronic heart failureDeddo Moertl, Rudolf Berger, Martin Huelsmann, et al.
European Journal of Heart Failure|March 25, 2008
Prognostic value of sequential measurements of amino-terminal prohormone of B-type natriuretic peptide in ambulatory heart failure patientsDeddo Moertl, Alexandra Hammer, Martin Huelsmann, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 22, 2004
Neurohumoral and hemodynamic effects of the selective endothelin antagonist darusentan in advanced chronic heart failureJutta Bergler-Klein, Richard Pacher, Rudolf Berger, et al.
BMJ Open|July 12, 2022
Socioeconomic environment and survival in patients after ST-segment elevation myocardial infarction (STEMI): a longitudinal study for the City of ViennaSonja Spitzer, Vanessa di Lego, Michael Kuhn, et al.
Pageof 8